Gilead Sciences CEO Daniel Patrick O'Day reports sale of $19.69 million in shares
GILD•Gilead Sciences Chairman and CEO Daniel Patrick O'Day sold 112,429 common shares on Nov. 4-5, 2026, for about $19.69 million. He exercised non-qualified stock options to acquire the same number of shares at $72.34 each.
1. Share sale
O'Day sold 102,619 shares on Nov. 4 at $175.1627 per share and 9,810 shares on Nov. 5 at $175.17 per share. He exercised non-qualified stock options to acquire the same number of shares at $72.34 each. His remaining direct holdings totaled 551,683 common shares and 128,310 non-qualified stock options.
